Trial Profile
Pragmatic Randomized Controlled Trial Comparing Treatment Effectiveness of Guideline Indicated Anti-platelet Therapy for Acute Coronary Syndrome in Patients With Chronic Kidney Disease
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 05 May 2020
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin; Clopidogrel
- Indications Acute coronary syndromes
- Focus Adverse reactions
- Acronyms CPRS-CKD
- 16 May 2017 New trial record